Scientific Mind

Dr. Essam Enan

Founder of GENVIRO, inventor of 50+ patents, and pioneer of molecular target pathways for plant essential oils.

Essam Enan

Ph.D., MSc., DPH

"Father of Plant Essential Oils"

40+ Years Research Experience
100+ Published Peer-Reviewed Papers
Inventor of 50+ Global Patents

A Lifetime of Scientific Discovery

Dr. Essam Enan is the founder of GENVIRO and the scientific mind behind our technology. He was the first in the world to discover the mode of action of plant essential oils and published several scientific papers in peer-reviewed journals on his discoveries. His discoveries have since been used in many products found on the market today. His expertise on the potential uses and benefits of plant essential oils is unmatched.

He has over 40 years of academic and industrial research experience in pesticide chemistry, toxicology, vector control, biochemistry, molecular biology, and G-protein coupled receptors. He has dedicated his career to building a bridge between natural botanical defenses and high-grade molecular science.

Dr. Enan is passionate about providing environmentally safe and all-natural products that will greatly improve the quality of life for animals, plants, and humans, and has spent his career perfecting his science and inventions to achieve this goal.

Timeline

Key Discoveries & Breakthroughs

A history of Dr. Enan's molecular discoveries and their commercial impact on the natural insecticides industry.

1996

Discovery of Receptor Targeting

Discovered that octopamine receptors in insects are primary targets for plant essential oils. This discovery helped an insecticide startup raise millions of dollars to successfully produce and commercialize effective natural insecticides.

2003

Cell-Based Screening Platform

Invented a high-throughput, cell-based screening platform to identify and engineer synergistic essential oil blends. This screening technology led to the creation of a pest control company that eventually went public on the London Stock Exchange.

2004

Cloning Octopamine Receptor

Became the first in the world to clone the octopamine receptor in insects, publishing the sequence mapping and receptor activation cascades in top peer-reviewed molecular biology journals.

2014

Proprietary Genviro Platform

Developed the proprietary platform that serves as the foundation and secret of success for all of GENVIRO's high-potency products, maximizing botanical pesticide stability and effectiveness.